I. Logeart

Using patients' and rheumatologists' opinions to specify a short form of the WOMAC function subscale (2005)

Tubach, F, Baron, G, Falissard, B, Logeart, I, Dougados, M, Bellamy, N, ...

Background: The WOMAC ( Western Ontario and McMaster Universities) function subscale is widely used in clinical trials of hip and knee osteoarthritis. Reducing the number of items of the subscale...

Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement (2005)

Tubach, F, Ravaud, P, Baron, G, Falissard, B, Logeart, I, Bellamy, N, ...

Background: In clinical trials, at the group level, results are usually reported as mean and standard deviation of the change in score, which is not meaningful for most readers. Objective: To...

Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state (2005)

Tubach, F, Ravaud, P, Baron, G, Falissard, B, Logeart, I, Bellamy, N, ...

Background: The patient acceptable symptom state ( PASS) is the value beyond which patients can consider themselves well. This concept can help in interpreting results of clinical trials. Objective:...

Evaluation of clinically relevant changes and states in symptomatic outcome variables in osteoarthritis (2003)

Tubach, F., Baron, G., Ravaud, P., Falissard, B., Logeart, I., Bombadier, C., ...

Evaluation of clinically relevant changes and states in symptomatic outcome variables in osteoarthritis of the lower limbs (2003)

Tubach, F., Ravaud, P., Baron, G., Falissard, B., Logeart, I., Bellamy, N., ...

Development of a French short form of the WOMAC function scale based on the patients' and experts' perspective (2003)

Tubach, F., Baron, G., Falissard, B., Logeart, I., Dougados, M., Bellamy, N., ...

Development of a French short form of the WOMAC function scale based on the patients' and experts' perspective (2003)

Tubach, F., Baron, G., Falissard, B., Logeart, I., Dougados, M., Bellamy, N., ...

Evaluation of clinically relevant changes and states in symptomatic outcome variables in osteoarthritis (2003)

Tubach, F., Baron, G., Ravaud, P., Falissard, B., Logeart, I., Bombadier, C., ...

Management of osteoarthritis (OA) with an unsupervised home based exercise programme and/or patient administered assessment tools. A cluster randomised controlled trial with a 2x2 factorial design

Ravaud, P, Giraudeau, B, Logeart, I, Larguier, J, Rolland, D, Treves, R, ...

Background: Diary recording of pain and disabling activities in osteoarthritis (OA) is widely recommended, but, to our knowledge, its impact on symptoms has not been investigated. Exercise programmes...

Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state

Tubach, F, Ravaud, P, Baron, G, Falissard, B, Logeart, I, Bellamy, N, ...

Background: The patient acceptable symptom state (PASS) is the value beyond which patients can consider themselves well. This concept can help in interpreting results of clinical trials.

Using patients' and rheumatologists' opinions to specify a short form of the WOMAC function subscale

Tubach, F, Baron, G, Falissard, B, Logeart, I, Dougados, M, Bellamy, N, ...

Background: The WOMAC (Western Ontario and McMaster Universities) function subscale is widely used in clinical trials of hip and knee osteoarthritis. Reducing the number of items of the subscale...

Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement

Tubach, F, Ravaud, P, Baron, G, Falissard, B, Logeart, I, Bellamy, N, ...

Background: In clinical trials, at the group level, results are usually reported as mean and standard deviation of the change in score, which is not meaningful for most readers.

Predictive factors of total hip replacement due to primary osteoarthritis: a prospective 2 year study of 505 patients

Gossec, L, Tubach, F, Baron, G, Ravaud, P, Logeart, I, Dougados, M

Objectives: To determine the 2 year total hip replacement (THR) rate and to identify factors predictive of THR due to primary osteoarthritis (OA).